Lothar Krinke’s Post

MedChi has the pleasure of hosting several events which emphasize the importance of our history, while investing in our future. Medicine has made many strides, and our conversations and discussions profoundly impact Maryland’s practitioners and communities. Communicative problem solving and exploration allows us to introduce new perspectives and improve current practices and policies moving forward. Thanks to events like these we can continue to invest in MedChi’s future. Read more in #MedChiNews - https://lnkd.in/eXxCGEuX

🔬 Exciting Update from OniX AI! 🔍 Delve into our latest preclinical reports covering key areas such as:#Osteoporosis, #Osteoarthritis, #RheumatoidArthritis, #Crohn's Disease, #LungCancer, #ColorectalCancer, #PediatricThalassemia, #StargardtDisease, and #HidradenitisSuppurativa. Here's a glimpse into what our reports cover: (i) Research Question: Our reports delve deep into pressing research questions, exploring the forefront of scientific inquiry and uncovering innovative solutions to complex medical challenges. (ii) Stage of Development: We provide comprehensive insights into the developmental stage of various projects, from initial discovery to advanced preclinical phases, offering a roadmap for progress and potential breakthroughs. (iii) Methods: With meticulous detail, we outline the methodologies employed in research, showcasing the rigorous scientific approach driving investigations and ensuring robust results. (iv) Drug Development Opportunity: Perhaps most importantly, our reports identify promising opportunities for drug development, illuminating pathways towards impactful therapies that have the potential to transform patient care. 💡 At OniX, we're dedicated to driving scientific discovery and catalyzing progress in healthcare. Stay tuned for more updates as we continue to push the boundaries of innovation! #OniXAI #PreclinicalResearch #DrugDevelopment #HealthcareInnovation #ScientificDiscovery 🧬💊 https://lnkd.in/d_bPbcD

Amgen continues to drive scientific discovery forward, particularly in targeted protein degradation and induced proximity research. Discover more from one of the people that started this remarkable revolution in science @Ray Deshaies, and his recent talk at the Medicine at the Crick symposium. #MyCompany

Catailyst Clinical Event Snippet: First Patient Enrolled/Dosed, Phase 2B MindBio Therapeutics Major Depressive Disorder Phase 2B Take-Home Microdosing (MB22001) Clinical Trial Follows successful Phase 2A trial where 53% of depressed patients were in complete remission from their depression at week 8 marked by a mean 14.1 point drop in MADRS score (Montgomery-Asberg Depression Rating Scale), a 60% mean drop in depressive symptoms. #cns #biotech #depression #biopharma https://lnkd.in/eMddutyN

Surge's €7.5M Funding Round: A Boon for Telemedicine & African Healthcare   The successful €7.5 million fundraising by SurgeCare, a European company pioneering immune system decryption for precision medicine, caught my attention. While Surge itself isn't African, its focus on personalized healthcare solutions resonates deeply with Africa's evolving telemedicine and telehealth space.   Here's why this is exciting news: Precision medicine holds immense potential: Tailoring treatments based on individual needs can significantly improve healthcare outcomes, where access to specialized care is limited. Surge's advancements can inspire VC trends: This significant investment by Eurazeo and other partners could encourage more VC interest in telemedicine solutions across Africa, leading to increased innovation and funding. SurgeLab™M and PreCyte® offer promising applications: These innovations focused on acquiring individualized immune signatures and predicting post-operative complications align perfectly with the need for remote diagnostics and personalized care in telemedicine. A bright future for African health: Surge's success story is a testament to the growing importance of personalized healthcare solutions. I'm optimistic that this will pave the way for more telemedicine advancements in Africa, ultimately improving the health and well-being of the continent's population.   Kudos to the SurgeCare team! Their dedication to precision medicine inspires us all. #telemedicine #africa #healthcare #precisionmedicine #venturecapital

🌟 Exciting News! 🌟 Business Oregon has awarded over $1.5 million in SBIR/STTR Matching Grants to 20 innovative small businesses across the state! These matching funds support companies advancing groundbreaking research and development, bringing cutting-edge technologies closer to market. We’re thrilled to celebrate this milestone with OBI client companies Madorra Inc., Vivifi Medical and OBI alumni Trace Biosciences among the awardees! Congrats to all recipients for driving progress and fueling small business growth! #OBI4You #SBIR #STTR https://lnkd.in/gH9kmg5D

Could you have survived being a pioneer? Recently, while watching 1883, the prequel to Yellowstone, I pondered the challenges faced by the pioneers. The Dutton family's journey from Tennessee to Montana post-civil war was filled with hardships - tornados, native Americans, bandits. Survival wasn't guaranteed, and many perished on the way. Reflecting on this, I realized the parallels with the challenges in our industry of Ortho Biologics/Regenerative medicine. Like pioneers, we face constant obstacles, skepticism, and mental stress. However, there is strength in numbers, just as there was in the pioneer days. At Mavirx, we aim to be your guide in navigating the landscape of challenges in growing a successful cash practice. Much like the guides who led wagon trains across the plains, our goal is to help you succeed and thrive. I am considering hosting an intensive, in-person event for a small group of 12 doctors on growing a successful cash practice. Whether you're starting up or already running a cash practice, this event will provide you with a roadmap to success. Your interest will determine if this event becomes a reality. If you're keen on spending a day with me before the year ends to gain insights and strategies for success, drop a comment below saying "Interested." Let's embark on this journey together.

We developed polymer-conjugated anticancer agent “TXB-001”, and joint nonclinical studies have confirmed key benefits. This agent significantly exhibits strong anticancer activity against various solid tumors and reduces several toxicities like cardiotoxicity.　https://lnkd.in/g3AqgnGq #globalhealth #healthcareinnovation #healthtech #anticancer #cardiotoxicity

Holistic Relationships: What's in Your Future GenZ & GenAlpha? Today @ 7pm CST…. Join Dr. Shante for a captivating live stream exploring the unique perspectives of life. #drshanterx #holisticrelationships #genz #genalpha #wellnesswednesday #wednesdaywisdom